Aurobindo Pharma Limited has informed the Exchange regarding a press release dated May 26, 2023, titled "Eugia Pharma receives USFDA Approval for Carboprost Tromethamine Injection USP 250 mcg/mL".
Aurobindo Pharma Limited has informed the Exchange regarding a press release dated May 26, 2023, titled "Eugia Pharma receives USFDA Approval for Carboprost Tromethamine Injection USP 250 mcg/mL".